Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NIKE

UnitedHealth Group

The Dow Jones Industrial Average is near record highs as the stock rally that began in spring 2023 continues. Comprised of 30 leading blue-chip stocks that are representative of the U.S. economy, the index is often referred to as the “Dow 30.

Exit Now! 3 Dow Stocks to Sell in February 2024

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that Chief Executive Officer, Tim Wentworth, and Global Chief Financial Officer, Manmohan Mahajan, will be presenting at the 44th Annual TD Cowen Health Care Conference, Monday, March 4 at 9:10 a.m. EST. An audio portion of the presentation will be webcast live and can be accessed through the Walgreens Boots Alliance investor relations website at https://investor.walgreensbootsalliance.com/press-relea.

Walgreens Boots Alliance to Participate in 44th Annual TD Cowen Health Care Conference

Petco Health and Wellness

SAN DIEGO , Feb. 13, 2024 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (Nasdaq: WOOF) today announced it has appointed Holly May as Chief Human Resources Officer (CHRO), effective February 4. In this role, May is responsible for driving an HR strategy that delivers profitable growth and outstanding performance, and is grounded in Petco's mission to improve lives for pets, pet parents and Petco partners.

Petco Names Holly May as Chief Human Resources Officer

Walgreens Boots Alliance has been hindered by drug reimbursement headwinds that have hurt its margins. Weak front store sales have also hurt the company. However, new CEO Tim Wentworth is laying the foundation for the company to turn itself around.

Walgreens: New CEO Looking To Right The Ship

Brandywine Realty

Intel

Newell Brands

AT&T

See The Top Credit Cards of 2024 – Unreal Bonuses (sponsored) The top credit cards of 2024 have just been released, and there are some incredible bonuses.

5 Well Known Stocks That Cut Their Dividends May Explode Higher in 2024

Chevron

Dow Inc

Hess

Verizon

Buy These 5 2024 Dogs of the Dow Dividend Leaders Now

Walgreens slashed its dividend last month. The pharmacy giant has been struggling due to challenging conditions.

Why Walgreens Boots Alliance Stock Slumped 13.6% in January

Walgreens Boots Alliance chief executive officer Tim Wentworth Thursday made an interim chief financial officer permanent and tapped a new head of the company's growing healthcare business as he fills his executive team.

Walgreens CEO Fills Out Executive Team, Sells Another Stake In Distributor For $992M

Walgreens Boots Alliance said on Thursday it has appointed Manmohan Mahajan as its chief financial officer, who was serving on an interim basis, ending the pharmacy chain's months-long search.

Walgreens appoints Manmohan Mahajan as finance chief

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance (Nasdaq: WBA) Chief Executive Officer Tim Wentworth today announced updates to WBA's Executive Committee as the company advances a health services strategy rooted in its retail pharmacy footprint. “Today's announcement solidifies the leadership team that will carry WBA into its future as we look to expand our reach beyond neighborhood pharmacies into the fastest-growing areas of healthcare,” said Wentworth. “We have a strong team with a.

Walgreens Boots Alliance Announces Leadership Appointments

Cencora Inc

U.S. drugstore chain Walgreens Boots Alliance on Wednesday said it has cut its stake in pharmaceutical distributor Cencora for the third time in just over six months, pocketing about $992 million.

Walgreens Boots pockets $992 mln after cutting Cencora stake for third time

In the latest trading session, Walgreens Boots Alliance (WBA) closed at $22.81, marking a -1.3% move from the previous day.

Walgreens Boots Alliance (WBA) Stock Falls Amid Market Uptick: What Investors Need to Know

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that it has sold shares of Cencora, Inc. (NYSE: COR) common stock pursuant to Rule 144 for proceeds of approximately $942 million and, subject to the completion of the Rule 144 sale, a concurrent share repurchase by Cencora in the amount of approximately $50 million. Walgreens Boots Alliance's ownership of Cencora's common stock has decreased from approximately 15 percent to approximately 13 percent.

Walgreens Boots Alliance Sells Shares of Cencora For $992 Million of Proceeds

AbbVie

Archer-Daniels-Midland Company

Amcor Plc

Air Products and Chemicals

Franklin Resources

Essex Property Trust

Fastenal

Federal Realty Investment Trust

Hormel Foods

Johnson & Johnson

Kimberly-Clark

Kenvue

NextEra Energy

Realty Income Corp

T. Rowe Price Group

V.F.

Exxon Mobil

"Dividend Aristocrats. in the S&P 500 Index… have raised their annual payouts every year for at least 25 consecutive years. "--Kiplinger.com. 67 Aristocrats, screened as of February 5, 2024 represented all eleven Morningstar Sectors. Broker estimated-top-ten net-gains ranged 11.95%-40.69% topped-by APD & ADM.

5 Dividend Aristocrats Signal Buy In February And 6 To Watch

United Rentals

Viking Therapeutics

Vizsla Silver Corp

Westamerica Bancorp

W. P. Carey

MoneyShow presents top investment ideas for 2024 from their contributors. This year's edition presents a broad mix of conservative income stocks, more speculative but potentially more rewarding growth stocks, as well as ETF recommendations that target commodities, cryptocurrencies, and fixed income. Part 9 of this series includes Verizon Communications, V.F. Corp, Vizsla Silver, Walgreens Boots Alliance and W. P. Carey, among others.

MoneyShow's Best Investment Ideas For 2024: Part 9

Verizon Communications Inc. NYSE: VZ, Walgreens Boots Alliance Inc. NASDAQ: WBA and 3M NYSE: MMM are among the highest-yielding components of the Dow Jones Industrial Average.

Verizon, Walgreens, 3M: 3 high-yield Dow stocks to buy now?

DEERFIELD, Ill.--(BUSINESS WIRE)--As a trusted, convenient local healthcare destination that millions of Americans rely on every day, Walgreens is expanding its long-standing relationships with colleges of pharmacy through the formation of the Walgreens Deans Advisory Council to enhance the pharmacy profession and better support pharmacists as they provide valuable care to their local communities. The new Council, consisting of 17 pharmacy school deans and Walgreens leadership, is sponsored by.

Walgreens Partners With Colleges of Pharmacy to Advance the Pharmacy Profession

Boeing

Salesforce

Cisco Systems

Disney

Goldman Sachs

Honeywell

JPMorgan Chase & Co

Coca-Cola

"The Dow® [adds a stock] if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors. Sector representation.is also a consideration.” – DowJones & Co. The highest-yield 10 stocks are February's Dogs of the Dow: GS, JNJ, KO, CSCO, IBM, CVX, WBA, DOW, VZ, and MMM. They only averaged a 4.19% annual yield, as prices. Thirty Dow stocks represent nine of eleven sectors. DowJones tracks utilities as a separate index and omits real estate. Broker top-ten target-estimated February net-gains ranged 10.99%-23.09%, topped by MMM 2/2/24.

February Dogs Of The Dow: Buy 2, Watch 5

New CEO Tim Wentworth is considering all options for improving the company's financials. In a decade, the company is likely to be much smaller and less complex than it is right now.

Where Will Walgreens Boots Alliance Be in 10 Years?

Caterpillar

Microsoft

For this month, the cycle/relative strength concept is applied. First, the Dow Jones 30 stocks are ranked from the best performer to the worst by calculating the expected return in that month.

Dow Stocks To Trade In February

Lockheed Martin

Procter & Gamble

Welcome to the intriguing intersection of dividends and growth, where 2024 unveils a captivating ensemble of seven must-have dividend stocks. Among investment choices, striking the right chord between consistent income and potential growth is a delicate art.

7 Must-Have Dividend Stocks for Consistent Income in 2024

Agree Realty

Dollar General

Essential Properties Realty Trust Inc

Extra Space Storage

NETSTREIT Corp

Public Storage

We highlight 2 such opportunities that we are buying.

2 REITs All Investors Should Own

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced the election of Robert L. (Robbie) Huffines to the company's board of directors at its 2024 Annual Meeting of Stockholders. He joins the board as an independent director and will serve on the board's Finance and Technology Committee. Huffines currently serves as Global Chairman of Investment Banking at J.P. Morgan Chase & Co., where he has guided healthcare companies for more than 30 years on stra.

Walgreens Boots Alliance Stockholders Elect Robert L. Huffines to Board of Directors

News for Walgreens Stock (WBA)